The Pfizer vaccine ‘against’ the Omicron variant could arrive in March 2022. Albert Bourla, CEO of the pharmaceutical company, speculates. “If the vaccine is needed, I believe we will have it in March,” Bourla said in response to a question in the Wall Street Journal’s CEO Council Summit.
“I don’t know if a specific vaccine will be needed,” we will know in a few weeks. Researchers are working to determine whether the current vaccine offers strong enough protection, the CEO adds. Pfizer has also focused on the antiviral pill, the Paxlovid. “We have a very high level of confidence, he will fight this variant and everything we have seen so far,” says Bourla, betting on the effectiveness of the drug. “We know that all those mutations” that characterize the Omicron variant “do not affect” the drug at all. “With the current variants, the ‘drug’ treatment we have should work at the same level.”
#Omicron #variant #Pfizer #vaccine #March #needed